Sign In

Use the Qualified Clinical Data Registry (QCDR) to complete Merit-Based Incentive Payment System reporting.

Report on evidence-based quality measures and receive performance scores via the Quality Oncology Practice Initiative (QOPI®).

Oncology Practice Insider

ASCO’s Oncology Practice Insider provides the latest news, information, and educational tools to assist with the successful management of oncology practice and the delivery of high quality patient care. OPI offers updates on ASCO programs, services, and cancer-related health policy, Medicare news, and billing and coding best practices. To sign up for the biweekly Oncology Practice Insider newsletter, please complete this form.

On March 22, 2018, the Food and Drug Administration approved nilotinib (TASIGNA®, Novartis Pharmaceuticals Corporation) for pediatric patients 1 year of age or older with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia in chronic phase (Ph+ CML-CP) or Ph+ CML-CP resistant or intolerant to prior tyrosine-kinase inhibitor (TKI) therapy. Read more.
On March 20, 2018, the Food and Drug Administration approved brentuximab vedotin (Adcetris®, Seattle Genetics, Inc.) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy. Read more.  
The Centers for Medicare and Medicaid Services (CMS) is hosting a listening session on Wednesday, March 21 from 1:30 PM to 3:00 PM EDT on potential updates to the Evaluation and Management (E/M) services to reduce burdens and better align coding and documentation with the current practice of medicine.  CMS is looking for physicians and non-physician practitioners who perform and bill E/M services; state and national associations that represent healthcare providers; and other interested stakeholders to participate.
CMS will begin mailing new Medicare cards to people with Medicare beginning in April. Below is a list of resources on CMS’ implementation activities and information that you need to know to get ready. Fact Sheet Overview webpage Provider webpage
The Centers for Medicare and Medicaid Services (CMS) has released a Medicare Learning Network (MLN) fact sheet on compliance tips for oral anticancer drugs and antiemetic drugs that are used in conjunction. The sheet provides a brief background, reasons for denials, and tips on preventing claim denials. Review or download the fact sheet. 
ASCO President Bruce E. Johnson, MD, FASCO, joined ASCO Chief Executive Officer Clifford A. Hudis, MD, FACP, FASCO, in the latest ASCO in Action Podcast to discuss the opportunities and challenges with precision medicine. While there is promise in precision medicine, Dr. Johnson notes there is work to be done, saying “The part that concerns me the most is being able to disseminate the information in a meaningful way to the people at the point of care who are taking care of these patients.”
ASCO now offers an oncology-focused, Introduction to Quality Improvement 1-Day Workshop where the esteemed faculty from the Quality Training Program (QTP) brings the same framework and tools to your practice. The 1-day workshop uses the same experience-based learning techniques used in the 5-day Quality Training Program, employing hands-on exercises and case studies. Whether you need an introductory course for 10 fellows or 35 multi-disciplinary team members, our 1-day workshop can be tailored to your needs.
ASCO’s new checklist, “Evaluating Oncology Clinical Pathways Programs,” guides oncology practices in examining the pathway programs they currently use or pathways under consideration for future use. When properly designed and implemented, oncology clinical pathways can improve care quality and reduce care costs.